CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2 Open-Label, Multicenter Trial of Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07066982
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:35.609288+00:00
Published At: 2025-07-15T00:00:00+00:00
Record Updated At: 2025-07-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Sarcoma", "Sarcoma, Kaposi", "Sarcoma, Ewing", "Sarcoma,Soft Tissue", "Sarcoma of Bone and Connective Tissue", "Sarcoma, Synovial", "Sarcoma Metastatic", "Sarcomas, Germinoblastic", "Sarcoma of Bone"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-15"
protocolSection.identificationModule.nctId: "NCT07066982"
protocolSection.identificationModule.officialTitle: "A Phase 1/2 Open-Label, Multicenter Trial of Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.